Managing Low Blood Pressure with Olmesartan Reduction

Recommendation

The European Society of Cardiology recommends targeting blood pressure that is "as low as reasonably achievable" (ALARA principle) while ensuring the treatment is well tolerated 1

Olmesartan medoxomil is typically dosed at 20-40 mg once daily for hypertension management, but dose adjustments are necessary when patients experience hypotension, as suggested by the American College of Cardiology 2

A blood pressure of 110/60 mmHg is at the lower end of normal range, and further reduction could lead to symptomatic hypotension, according to the American Heart Association 3

After reducing the olmesartan dose, blood pressure should be rechecked within 4 weeks to assess the response, as recommended by the European Society of Cardiology 4
Monitor for symptoms of hypotension such as dizziness, lightheadedness, or syncope, especially with position changes, as advised by the European Journal of Heart Failure 5
If blood pressure increases significantly after dose reduction, consider returning to the previous dose or adding a different class of antihypertensive medication with less hypotensive effect, as suggested by the European Heart Journal and the American College of Cardiology 1, 2

Consider the patient's overall cardiovascular risk profile when adjusting antihypertensive medications, as recommended by the European Society of Cardiology 1
If the patient has comorbid conditions like heart failure or coronary artery disease, different blood pressure targets may apply, and consultation with a specialist may be warranted, as advised by the European Journal of Heart Failure 5, 6